Hot Biotech Trades for Second-Half 2011

Description:

According to Adam Feuerstein, these biotech trades "encompass pending FDA drug approval decisions and clinical trial results -- all of which have the potential to produce significant stock-price volatility in the next six months." Read more here.

>>Also: 3 Funds' Best Stock Picks Ahead of Earnings

>>Also: 7 Best-Performing Dow Stocks

Most Viewed Portfolios

View All

Articles

5 Rocket Stocks for Gluttonous Turkey Day Gains

11.24.14 | 07:56 AM

BALTIMORE ( Stockpickr) -- This Thanksgiving, have your turkey and mashed potatoes with a side of stock gains. It may sound surprising, but statist...

Time to Sell These 5 'Toxic' Stocks

11.21.14 | 11:27 AM

BALTIMORE ( Stockpickr) -- Which stocks should I buy? It's the eternal question that most investors spend most of their time wondering. But is it t...

More Articles
blog comments powered by Disqus
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter